Log in

LONN Lonza Group AG SIX · Switzerland

Lonza Group (LONN) news

Lonza Group AG is a public biotech or pharmaceutical company listed on SIX under the ticker LONN, recorded under Switzerland. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Lonza Group news

We have not published a story on Lonza Group yet. When there is news, it will appear here.

Questions about Lonza Group

What is the ticker symbol of Lonza Group?

Lonza Group AG trades under the ticker LONN on SIX.

Where is Lonza Group listed?

Lonza Group AG is listed on SIX. Our directory also records these other listings: BX:LO3; DUS:LO3; FWB:LO3; GETTEX:LO3; HAM:LO3; HAN:LO3; LS:928619; LSE:0QNO; LSX:928619; MUN:LO3; NEO:LON; OTC:LZAGF; OTC:LZAGY; SWB:LO3; TRADEGATE:LO3; VIE:LONN; XETR:LO3.

Which country or territory is Lonza Group listed under?

Our directory records Lonza Group AG under Switzerland.

What does Lonza Group do?

Our directory classifies Lonza Group AG as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Lonza Group?

The ISIN recorded for Lonza Group AG is CH0013841017.

Does aibio.space cover Lonza Group?

aibio.space lists Lonza Group AG among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Lonza Group?

Companies in our directory listed in the same country and business area as Lonza Group: MindMaze Therapeutics Holding SA, Molecular Partners, PolyPeptide Group, CRISPR Therapeutics, NewcelX, BioVersys.

Investor discussion: Lonza Group

Members talk about Lonza Group (LONN). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SIX:LONN on TradingView.

Listing details

Lonza Group AG is a public biotech or pharmaceutical company listed on SIX under the ticker LONN, recorded under Switzerland. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Lonza Group AG
Ticker
LONN
Listing
SIX
Country or territory
Switzerland
Business scope
Biotechnology
ISIN
CH0013841017
Other listed symbols
BX:LO3; DUS:LO3; FWB:LO3; GETTEX:LO3; HAM:LO3; HAN:LO3; LS:928619; LSE:0QNO; LSX:928619; MUN:LO3; NEO:LON; OTC:LZAGF; OTC:LZAGY; SWB:LO3; TRADEGATE:LO3; VIE:LONN; XETR:LO3
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.